
BKR · Nasdaq
Expected to report Jan 24, 2027 — estimated from last year’s reporting date.
Consensus is $0.67 EPS for Dec 2026 across 4 estimates, ranging $0.64 to $0.68.
Baker Hughes delivered a growth and order-visibility quarter, with adjusted EPS of $0.70 beating the $0.63 consensus and adjusted EBITDA reaching $1.415 billion, up 14% year over year. Revenue of $8.025 billion increased 14% from Q3 2025 and 19% from Q2 2026, though the year-over-year increase was primarily the result of adding Chart. Adjusted net income rose 2% year over year to $695 million. GAAP net income attributable to Baker Hughes, by contrast, declined 33% year over year and 40% sequentially to $411 million; GAAP EPS was $0.41 versus $0.61 a year earlier and $0.68 in Q2. Acquisition-related amortization, transaction costs and higher interest expense weighed on reported earnings.
The defining feature was IET’s continued order momentum: $5.9 billion in orders and record RPO of $39.4 billion prompted the company to raise its full-year IET order range and its 2026–2028 outlook. Chart’s first partial-quarter contribution added $888 million of revenue and $156 million of EBITDA, while integration and deleveraging become important execution priorities. OFSE also improved sequentially, helped by stronger international activity. Free cash flow remained solid at $769 million, although it was below Q2’s $1.109 billion; management expects $1.46 billion of adjusted EBITDA in Q4 and a full-year midpoint of $5.265 billion.